Study Stopped
COVID-19
VCH -- vAFC Phase 3
vAFC
The Virtual Atrial Fibrillation Clinic: Improving Specialty Care Delivery
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The purpose of this third phase of a three-phase study is to pilot a virtual AF clinic (vAFC) compared to usual onsite care provided by a specialty AF clinic. Older adults with AF will be recruited and randomized into either the vAFC (videoconference appointments with specialists at the Vancouver AF clinic, supplemented with educational content on an AF website developed from phase one results) or the usual care group (onsite appointments with specialists at the Vancouver AF clinic). This pilot will generate evidence to determine the feasibility of scaling up the vAFC model to other sites.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Mar 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 28, 2018
CompletedFirst Posted
Study publicly available on registry
April 30, 2018
CompletedStudy Start
First participant enrolled
March 12, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2022
CompletedNovember 4, 2020
November 1, 2020
1.7 years
March 28, 2018
November 2, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change from baseline Atrial Fibrillation Effect on Quality of Life (AFEQT)
Atrial Fibrillation Effect on QualiTy-of-Life Questionnaire (AFEQT), a 20 item, 7-point scale, with four domains: Symptoms, Daily Activities, Treatment Concerns, and Satisfaction.
baseline, 3 months and 6 months
Change from baseline Atrial Fibrillation Knowledge
Multiple choice survey with three response options, asking questions about atrial fibrillation, including questions regarding symptoms, treatment, medications, risk factors, and lifestyle.
baseline, 3 months and 6 months
Secondary Outcomes (14)
Healthcare Utilization
baseline, 3 months and 6 months
Perceived Stress
baseline, 3 months and 6 months
Smoking behaviour
baseline and 6 months
Alcohol consumption
baseline and 6 months
Nutrition
baseline and 6 months
- +9 more secondary outcomes
Study Arms (2)
Usual Care
NO INTERVENTIONControl group participants will be notified of their assignment and will continue their usual care with the AF clinic receiving onsite care. Participants will be contacted at 3 time points (baseline, 3 months, and 6 months)
Virtual Atrial Fibrillation Clinic
EXPERIMENTALParticipants in the intervention group can expect to receive between 1 and 4 telehealth appointments over a 6 month period, as well as being contacted by the research team at 3 time points for data collection (baseline, 3 months, and 6 months). Telehealth appointments will consist of remote interactions with clinicians. Telehealth appointments will take place in participants' homes, using their personal computer/tablet/smartphone. Participants will also receive an orientation to the website and will be encouraged to visit often and utilize the resources. To promote and encourage website interaction, emails will be sent to participants once semi-monthly for the duration of the intervention with highlights and important messages from the website.
Interventions
Participants in the intervention group will receive usual GP care plus the vAFC which consists of telehealth appointments with Nurse Practitioner/Cardiologist and access to an AF specific educational website. It is anticipated the vAFC, as with the onsite clinic, will include a maximum of four scheduled telehealth appointments: an initial appointment following randomization, at 4-6 weeks, 3 months, and 6 months.
Eligibility Criteria
You may qualify if:
- years or older;
- Patients with a diagnosis of atrial fibrillation confirmed through an ECG;
- first time patient at the AF Vancouver clinic;
- live outside Vancouver city;
- have no problems with memory and recall;
- will be English speaking or have a family member who can assist with reading, understanding and completing the consent and survey documents;
- able to give own consent to participate in this study;
- have access to a computer/tablet/laptop with reliable internet;
- participate voluntarily and freely.
You may not qualify if:
- if the participant seems like a poor candidate for virtual care based on the discretion of the AF clinic staff;
- cognitive impairment;
- uncompensated hearing impairment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of British Columbialead
- Canadian Institutes of Health Research (CIHR)collaborator
- Interior Healthcollaborator
Study Sites (1)
University of British Columbia
Kelowna, British Columbia, V1V 1V7, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kathy L Rush, PhD
University of British Columbia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 28, 2018
First Posted
April 30, 2018
Study Start
March 12, 2020
Primary Completion
December 1, 2021
Study Completion
June 1, 2022
Last Updated
November 4, 2020
Record last verified: 2020-11